% | $
Quotes you view appear here for quick access.

Sanofi Message Board

  • basset_hound_rancher basset_hound_rancher Aug 13, 2002 12:19 PM Flag

    Interesting Perspective on Eloxatin

    from Forbes. While Eloxatin make not be a medical breakthrough, it should be a huge seller because of the unmet medical need. Sounds like a plan to me.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Some of you don't know how huge this is. They got approval second line but it will be used first line in some cases. I think once physicians find out how well it works in combination with other agents it will be a blockbuster. Looks good in other tumors. I think we will see 500million in sales by the end of the second year. We could have a billion in sales if they market and do the studies right. I did hear that Pharmacia/PFE is scared about losing their key folks to Sanofi. They are offering cash bonus for those that stay on. 32 is a steal. The stock should have jumped 5-7 points on this news. Shows you how hopeless the market is. Once things settle down pharma stocks will soar as long as we can keep that bitch Hilary out of office. She has a girl lover you know! I hear she flies to Florida once a week to see Janet Reno. Oh my Janet your so hot I hope you can be my V.P.!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

    • According to the company, it has sales of about $7 billion a year.

      The Camptosar market was $600 million last year. Say they get half of that-- it's only about 4-5% increase in revenue.

      Maybe that's why the stock hasn't rocketed.



38.90-0.03(-0.08%)12:44 PMEDT